VIDEO: Glaucoma 360 brings together actors in glaucoma treatment innovation

SAN FRANCISCO – Thomas M. Brunner, president and chief executive officer of the Glaucoma Research Foundation, discusses the New Horizons Forum, gala dinner and CME program that constitute Glaucoma 360, a 3 day event that brings together glaucoma specialists, members of industry and venture capitalists to discuss the latest innovations in glaucoma surgery and therapeutics.

Minimum effective dose: A prescription for success

When I ask my patients, “What do you do?” they invariably answer by telling me what their job is. This is pretty much standard fare everywhere in the U.S. except California. If you ask a Californian what it is that he or she does, you will get the same sort of reply as I receive from my follow-up question to my patients in Ohio: “What do you do for fun?” Those of you who know me a little better than others know that my answer to question No. 2 — (Read more...)

Glued IOL scaffold can be used to manage Soemmering’s ring

Soemmering’s ring was first described by D.W. Soemmering and is considered to be a type of regenerating lens substance that has a peripheral disposition and often goes unrecognized unless it is centrally dislocated or the pupil is widely dilated. The incidence of Soemmering’s ring formation is higher in pediatric cases after cataract surgery. Retention of lens fibers between the anterior and posterior capsules is considered to be the possible etiology. The adhesions of the anterior and posterior capsules prevent the exposure of these lens fibers to the aqueous and the (Read more...)